Nile Misr Healthcare is currently doing due diligence on six potential investment targets, CEO Tarek Moharram told the local press. The USD 380 mn fund, launched last week by Misr Capital and Elevate Private Equity, is looking at companies in the fields of hospitals, labs, radiology centers and private medical ins., he said, adding that it will soon acquire one of “the most important” diagnostic companies in Egypt. The companies are targeting a USD 150 mn first close for the fund during 1Q2022 and are looking to invest in Egypt, Ghana, Nigeria, Kenya and Cote d’Ivoire, they said last week.

IPO on the horizon: Nile Misr Healthcare’s long-term ambition is to bring a number of its portfolio companies under the umbrella of a holding company, which would then be floated on the EGX, Moharram said.